Congratulations to Principal Investigator Marcel Wüthrich, PhD, on his recent R01 award of over $2.2 million for his grant, “Regulation of vaccine-induced anti-fungal Th17 cells,” from the National Institutes of Health – National Institute of Allergy and Infectious Diseases (NIH-NIAID). This 4-year renewal, in collaboration with Bruce Klein, MD, Co-Investigator, provides funding for Years 6-9 of this project, which will investigate a novel adjuvant that elicits cellular immune responses needed for better vaccines. The lack of an appropriate adjuvant is one major barrier to developing a safe and effective vaccine against infections with fungal pathogens, which represents an unmet need in medicine and public health.